Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetyl-L-Carnitine for Hypertension and Dyslipidemia in Type 2 Diabetes
NCT00984750Phase 3Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Apr 2008
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetyl-l-carnitine in hypertension (HTN), dyslipidemia, sponsored by Mario Negri Institute for Pharmacological Research. Started Apr 2008; status: completed.
02
Drugs
acetyl-l-carnitine
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT00984750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00984750.